Randomized phase II study to compare docetaxel plus S-1 with cisplatin plus S-1 in advanced gastric cancer without measurable lesions (HERBIS-3)

被引：1
|
作者：
Matsuyama, Jin
Kurokawa, Yukinori
Nishikawa, Kazuhiro
Kimura, Yutaka
Takeno, Atsushi
Kawada, Junji
Kawabata, Ryohei
Makari, Youichi
Tamura, Shigeyuki
Doki, Yuichiro
Sakai, Daisuke
Shimokawa, Toshio
Satoh, Taroh
机构：
[1] Yao Municipal Hosp, Yao, Japan
[2] Osaka Univ, Grad Sch Med, Osaka, Japan
[3] Osaka Natl Hosp, Osaka, Japan
[4] Kindai Univ, Osaka, Japan
[5] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan
[6] Kaizuka City Hosp, Osaka, Japan
[7] Osaka Rosai Hosp, Sakai, Osaka, Japan
[8] Sakai City Med Ctr, Sakai, Osaka, Japan
[9] Wakayama Med Univ, Wakayama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.119
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
119
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Docetaxel plus S-1 versus cisplatin plus S-1 in unresectable gastric cancer without measurable lesions: a randomized phase II trial (HERBIS-3)
    Kurokawa, Yukinori
    Matsuyama, Jin
    Nishikawa, Kazuhiro
    Takeno, Atsushi
    Kimura, Yutaka
    Fujitani, Kazumasa
    Kawabata, Ryohei
    Makari, Yoichi
    Terazawa, Tetsuji
    Kawakami, Hisato
    Sakai, Daisuke
    Shimokawa, Toshio
    Satoh, Taroh
    GASTRIC CANCER, 2021, 24 (02) : 428 - 434
  • [2] Docetaxel plus S-1 versus cisplatin plus S-1 in unresectable gastric cancer without measurable lesions: a randomized phase II trial (HERBIS-3)
    Yukinori Kurokawa
    Jin Matsuyama
    Kazuhiro Nishikawa
    Atsushi Takeno
    Yutaka Kimura
    Kazumasa Fujitani
    Ryohei Kawabata
    Yoichi Makari
    Tetsuji Terazawa
    Hisato Kawakami
    Daisuke Sakai
    Toshio Shimokawa
    Taroh Satoh
    Gastric Cancer, 2021, 24 : 428 - 434
  • [3] Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer
    Hosokawa, Ayumu
    Ando, Takayuki
    Ogawa, Kohei
    Ueda, Akira
    Yoshita, Hiroki
    Mihara, Hiroshi
    Fujinami, Haruka
    Kajiura, Shinya
    Yabushita, Kazuhisa
    Horikawa, Naoki
    Kobayashi, Yuka
    Yoshioka, Akira
    Origasa, Hideki
    Sugiyama, Toshiro
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (10): : 977 - 981
  • [4] A phase I/II study of S-1 plus cisplatin alternating with S-1 plus docetaxel in patients with advanced gastric cancer (AGC)
    Hosokawa, A.
    Ogawa, K.
    Kajiura, S.
    Tsukioka, Y.
    Kobayashi, T.
    Horikawa, N.
    Kobayashi, Y.
    Yoshioka, A.
    Sumi, S.
    Sugiyama, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [5] Efficacy and tolerability of docetaxel and cisplatin plus S-1 for advanced gastric cancer
    Luo, Haiqing
    Yu, Zhonghua
    Gao, Hongfei
    Guan, Chengnong
    Xu, Meng
    JOURNAL OF BUON, 2013, 18 (01): : 154 - 161
  • [6] A randomized phase II trial of docetaxel plus S-1 versus docetaxel plus cisplatin in advanced gastric cancer as a first-line treatment
    Jeung, H.
    Im, C.
    Rha, S.
    Ahn, J.
    Shin, S.
    Noh, S.
    Roh, J.
    Chung, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Randomized, multicenter, phase III trial to compare S-1 plus docetaxel (DS) with S-1 plus cisplatin (SP) in gastric cancer patients with stage III (POST trial).
    Lee, Choong-kun
    Jung, Minkyu
    Kang, Seok Yun
    Kim, Bong-Seog
    Kim, Ki Hyang
    Lee, Kyung Hee
    Lee, Moon Hee
    Shin, Dong Bok
    Zang, Dae Young
    Ahn, Ji Yeong
    Kim, Hyoung-il
    Hyung, Woo Jin
    Noh, Sung Hoon
    Kim, Hyo Song
    Chung, Hyun Cheol
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Randomized phase III study of S-1 plus oxaliplatin versus S-1 plus cisplatin for first-line treatment of advanced gastric cancer
    Higuchi, Katsuhiko
    Koizumi, Wasaburo
    Yamada, Yasuhide
    Nishikawa, Kazuhiro
    Gotoh, Masahiro
    Fuse, Nozomu
    Sugimoto, Naotoshi
    Nishina, Tomohiro
    Amagai, Kenji
    Chin, Keisho
    Niwa, Yasumasa
    Negoro, Yuji
    Imamura, Hiroshi
    Tsuda, Masahiro
    Yasui, Hirotumi
    Fujii, Hirofumi
    Yamaguchi, Kensei
    Yasui, Hisateru
    Hamada, Chikuma
    Hyodo, Ichinosuke
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [9] Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
    Koizumi, W.
    Yamaguchi, K.
    Hosaka, H.
    Takinishi, Y.
    Nakayama, N.
    Hara, T.
    Muro, K.
    Baba, H.
    Sasaki, Y.
    Nishina, T.
    Fuse, N.
    Esaki, T.
    Takagi, M.
    Gotoh, M.
    Sasaki, T.
    BRITISH JOURNAL OF CANCER, 2013, 109 (08) : 2079 - 2086
  • [10] Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
    W Koizumi
    K Yamaguchi
    H Hosaka
    Y Takinishi
    N Nakayama
    T Hara
    K Muro
    H Baba
    Y Sasaki
    T Nishina
    N Fuse
    T Esaki
    M Takagi
    M Gotoh
    T Sasaki
    British Journal of Cancer, 2013, 109 : 2079 - 2086
12345